Thursday, August 14, 2025

CluePoints Names Usama Dar Chief Product & Tech Officer

Related stories

AI Agent Orchestration Explained: What It Is and Why It Matters

For years, we've marveled at individual AI agents. They...

Advarra Launches Braid™ to Enhance Clinical Trials with AI

Powered by the industry's largest set of digitized protocols...

Qubrid AI Launches 2-Step No-Code Multimodal RAG Service

Qubrid AI, a leader in high-performance GPU Cloud solutions,...

SiMa.ai Unveils Next-Gen Platform for Physical AI Production

Modalix™ in Production, Now Shipping SoM Pin-Compatible with leading...

Squint Secures $40M Series B to Advance Agentic Manufacturing

Squint, the leading Manufacturing Intelligence Platform, today announced it...
spot_imgspot_img

CluePoints, provider of leading statistical and AI-driven software solutions, has announced Usama Dar as its new Chief Product and Technology Officer. Having led both product and R&D teams through significant expansion, Usama is ideally placed to help CluePoints in the next phase of its growth journey.

Usama has worked in leadership roles across some exciting organizations, including Westwing, Sciensus, Elsevier, The Guardian and Huawei. With a career spanning eCommerce, SaaS, and AI, he loves building and leading teams to create impactful products.

Andy Cooper, CEO at CluePoints, commented: “CluePoints has gone from being a very successful single-product company to a multi-product company undergoing a period of rapid growth, both in terms of people and our platform. Usama is the perfect fit to support us on our journey to provide the most comprehensive, and highest quality, Integrated Data Review platform for the Clinical Development industry.”

Also Read: Sanctuary AI New Tactile Sensors Enable Richer Sense of Touch

Usama Dar reiterated the opportunities for growth at CluePoints: “What attracted me to CluePoints was its mission to harness technology to improve and accelerate clinical trials, the people working within the organization and the difference I can make. CluePoints is at a sweet spot in its growth where it has a proven idea which is popular with customers. Now it needs to scale to more customers, more geographies and different parts of the clinical trial life cycle. I look forward to using my extensive engineering experience and product background to streamline product development, scale CluePoints‘ offering and take it to the next level.”

Andy Cooper added: “Usama brings a strong vision of where our focus should be and what we need to bring from a technology perspective to ensure we do not just grow successfully but also provide best-in-class technology to underpin our products and ensure our customers are satisfied and can scale with us. Usama will be working closely with our existing team, including co-founder, Francois Torche, who will continue to lead the vision for our product portfolio as a strategic advisor.”

Source: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img